Treatment of Huntington's Disease by Inhibition of Caspase-6 Cleavage Using CRISPR Base Editing

被引：0
|
作者：
Shirguppe, Shraddha [1 ]
机构：
[1] UIUC, Dept Bioengn, Urbana, IL USA
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
1562
引用
收藏
页码：734 / 734
页数：1
相关论文
共 50 条
  • [21] Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease
    Ona, VO
    Li, MW
    Vonsattel, JPG
    Andrews, LJ
    Khan, SQ
    Chung, WM
    Frey, AS
    Menon, AS
    Li, XJ
    Stieg, PE
    Yuan, JY
    Penney, JB
    Young, AB
    Cha, JHJ
    Friedlander, RM
    NATURE, 1999, 399 (6733) : 263 - 267
  • [22] Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease
    Victor O. Ona
    Mingwei Li
    Jean Paul G. Vonsattel
    L. John Andrews
    Sohail Q. Khan
    Woosik M. Chung
    Ariel S. Frey
    Anil S. Menon
    Xiao-Jiang Li
    Philip E. Stieg
    Junying Yuan
    John B. Penney
    Anne B. Young
    Jang-Ho J. Cha
    Robert M. Friedlander
    Nature, 1999, 399 : 263 - 267
  • [23] CRISPR-CAS9 NICKASE-MEDIATED GENE EDITING TO TREAT HUNTINGTON'S DISEASE
    Murillo, Alvaro
    Larin, Meghan
    Randall, Emma L.
    Taylor, Alysha
    Lelos, Mariah
    Dion, Vincent
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 : A86 - A86
  • [24] Thioredoxin system as a gatekeeper in caspase-6 activation and nuclear lamina integrity: implications for Alzheimer's disease
    Islam, Md. Imamul
    Pandian, Nagakannan
    Ogungbola, Olamide
    Dordevic, Jelena
    Albensi, Benedict
    Eftekharpour, Eftekhar
    FREE RADICAL BIOLOGY AND MEDICINE, 2018, 128 : S132 - S132
  • [25] Caspase-6 Truncated Tau Play A Major Role In Alzheimer's Disease: Diagnostic And Therapeutic Implications
    Theofilas, Panos
    Piergies, Antonia
    Cathrine, Petersen
    Wang, Chao
    Butler, David
    Li, Song Hua
    Chin, Brian
    Yang, Teddy
    Khan, Shireen
    Ng, Ramond
    Spina, Salvatore
    Seeley, William
    Miller, Bruce
    Gan, Li
    Gestwicki, Jason
    Karch, Celeste
    Temple, Sally
    Arlin, Michelle
    Grinberg, Lea Tenenholz
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2021, 80 (06): : 583 - 583
  • [26] Thioredoxin system as a gatekeeper in caspase-6 activation and nuclear lamina integrity: Implications for Alzheimer's disease
    Islam, Md Imamul
    Nagakannan, Pandian
    Ogungbola, Olamide
    Djordjevic, Jelena
    Albensi, Benedict C.
    Eftekharpour, Eftekhar
    FREE RADICAL BIOLOGY AND MEDICINE, 2019, 134 : 567 - 580
  • [27] Base editing strategies to convert CAG to CAA diminish the disease-causing mutation in Huntington's disease
    Choi, Doo Eun
    Shin, Jun Wan
    Zeng, Sophia
    Hong, Eun Pyo
    Jang, Jae-Hyun
    Loupe, Jacob M.
    Wheeler, Vanessa C.
    Stutzman, Hannah E.
    Kleinstiver, Ben
    Lee, Jong-Min
    ELIFE, 2024, 12
  • [28] CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington's disease
    Yang, Su
    Chang, Renbao
    Yang, Huiming
    Zhao, Ting
    Hong, Yan
    Kong, Ha Eun
    Sun, Xiaobo
    Qin, Zhaohui
    Jin, Peng
    Li, Shihua
    Li, Xiao-Jiang
    JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (07): : 2719 - 2724
  • [29] Response inhibition in Huntington's disease - A study using ERPs and sLORETA
    Beste, Christian
    Saft, Carsten
    Andrich, Juergen
    Gold, Ralf
    Falkenstein, Michael
    NEUROPSYCHOLOGIA, 2008, 46 (05) : 1290 - 1297
  • [30] CRISPR-Cas9-mediated genome editing improves motor deficits and lifespan in a mouse model of Huntington's disease
    Ekman, F. K.
    Ojala, D. J.
    Adil, M.
    Lopez, P. A.
    Schaffer, D. V.
    Gaj, T.
    HUMAN GENE THERAPY, 2019, 30 (11) : A90 - A90
12345